What is Alevio?
Alevio Spine is dedicated to advancing the treatment of sacroiliac joint pain through innovative, minimally invasive surgical solutions. Their flagship offering, the SI-Cure Implant System, is engineered to provide physicians with versatile options for optimizing patient care. The company actively engages in educating both healthcare professionals and patients about the complexities of SI joint pain and the efficacy of surgical interventions like SI joint fusion. Alevio's focus on specialized orthopedic solutions positions it as a key player in addressing chronic low back pain originating from the sacroiliac joint.
How much funding has Alevio raised?
Alevio has raised a total of $420K across 2 funding rounds:
Debt
$150K
Debt
$270K
Debt (2020): $150K with participation from PPP
Debt (2021): $270K led by PPP
What's next for Alevio?
With its recent large-scale, late-stage funding, Alevio is poised for significant expansion. The strategic investment signals strong investor confidence in the company's technology and market strategy. This capital infusion will likely be directed towards scaling manufacturing capabilities, expanding clinical adoption of the SI-Cure Implant System, and potentially pursuing further research and development for next-generation treatments. Alevio's trajectory suggests a focus on market penetration and establishing broader healthcare system integration.
See full Alevio company page
